Exactech to Present at the 2008 Noble Financial Equity Conference on August 18
GAINESVILLE, Fla. -- August 5, 2008 -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Fourth Annual Noble Financial Equity Conference. The two-day conference will showcase 150 small cap public companies at the Loews Lake Las Vegas Resort, Nevada.
GAINESVILLE, Fla. -- August 5, 2008 -- Exactech Inc.
(Nasdaq: EXAC), a developer and producer of bone and joint restoration
products for hip, knee, shoulder, spine and biologic materials, will
present at the Fourth Annual Noble Financial Equity Conference. The
two-day conference will showcase 150 small cap public companies at the
Loews Lake Las Vegas Resort, Nevada.
President David Petty and CFO Jody Phillips will give a
presentation on Exactech’s market positioning, products, financial
performance and strategic direction at 3:30 p.m. Pacific Time on
Monday, August 18, and will host a question and answer session after
the presentation. Throughout the two-day conference Petty and Phillips
will also host one-on-one meetings with investors.
The presentation with streaming video and PowerPoint slides will be webcast live and archived at www.hawkassociates.com/clients/additional/index.cfm?client_id=5 and Noble Financial’s conference website at: www.noblemadmax.com.
About Noble Financial
Noble Financial is a privately-held,
full-service capital markets firm focused on converting market
inefficiencies into profit opportunities. Noble Financial supports
emerging companies through strategic advice, investment banking,
market-making, sales and trading, comprehensive equity research, and
the development of institutional support. The company has operated for
24 years and has offices in Florida, New York City and Boston. For
additional information, visit: www.nobleresearch.com.
About Exactech
Based in Gainesville, Florida, Exactech develops and markets
orthopaedic implant devices, related surgical instruments and biologic
materials and services to hospitals and physicians. The company
manufactures many of its orthopaedic devices at its Gainesville
facility. Exactech’s orthopaedic products are used in the restoration
of bones and joints that have deteriorated as a result of injury or
diseases such as arthritis. Exactech markets its products in the United
States and Australia, in addition to more than 30 markets in Europe,
Asia and Latin America. Additional information about Exactech, Inc. can
be found at www.exac.com.
Copies of Exactech’s press releases, SEC filings, current price quotes
and other valuable information for investors may be found at www.exac.com and www.hawkassociates.com.
An Exactech investment profile is online at www.hawkassociates.com/profile/exac.cfm.
Investors may contact Chief Financial Officer Jody Phillips at
352.377.1140 or Julie Marshall or Frank Hawkins, Hawk Associates at
305.451.1888, e-mail: exactech@hawkassociates.com. To receive e-mail alerts about EXAC, sign up at www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements
